Colonoscopy: quality indicators.

Colonoscopy: quality indicators.
复制标题

DOI:
10.1038/ctg.2015.5
复制
发表时间:
2015-02-26
影响因子:
3.6
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

结直肠癌(CRC)是少数几种可预防的癌症之一,有效的内镜筛查取决于对潜在癌前病变的充分检测和切除。然而,在实践和结果中观察到的结肠镜检查性能的变化突出了一致的质量措施的必要性。质量指标或衡量标准是帮助量化保健过程的工具,有助于提供高质量的保健。结肠镜检查的主要质量指标是腺瘤检出率(ADR),其定义为内镜医师筛查结肠镜检查中检出一个或多个腺瘤的比例。结肠镜检查后CRC的风险与内镜医师的ADR呈负相关。然而,ADR取决于其他质量指标,包括盲肠插管率、停药时间和肠道准备质量。达到这些其他质量指标的建议基准将有助于内窥镜医师在其实践中达到最近更新的ADR基准25%。此外,除了确保充分的ADR,内镜医师还应该对指南推荐的循证筛查和监测间隔有较高的依从率。遵守质量措施将确保有效和安全的CRC预防和更好的患者结局。
Effective endoscopic screening for colorectal cancer (CRC), one of the few preventable cancers, is dependent on the adequate detection and removal of potentially precancerous lesions. However, observed variation in colonoscopy performance in practice and outcomes has highlighted the need for consistent quality measures. Quality indicators or measures are tools that help to quantify health-care processes and can aid in providing high-quality health care. The primary colonoscopy quality indicator is the adenoma detection rate (ADR), which is defined as the proportion of an endoscopist's screening colonoscopies in which one or more adenomas have been detected. The risk of post-colonoscopy CRC is inversely correlated with an endoscopist's ADR. However, ADR is dependent on other quality measures, including cecal intubation rates, withdrawal times, and quality of bowel preparation. Achieving suggested benchmarks for these other quality measures will aid the endoscopist in achieving the recently updated ADR benchmark of 25% in their practice. In addition, beyond ensuring adequate ADRs, endoscopists should have high compliance rates with guideline-recommended and evidence-based screening and surveillance intervals. Compliance with quality measures will ensure effective and safe CRC prevention and better patient outcomes.
DOI: 10.1053/j.gastro.2009.10.054
发表时间: 2010-03-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Brenner, Hermann;Haug, Ulrike;Hoffmeister, Michael
通讯作者: Hoffmeister, Michael
DOI: 10.1016/j.gie.2012.10.023
发表时间: 2013-03-01
影响因子: 7.7
作者:
Do, Albert;Weinberg, Janice;Jacobson, Brian C.
通讯作者: Jacobson, Brian C.
DOI: 10.1200/jco.2011.40.4772
发表时间: 2012-07-20
影响因子: 45.3
作者:
Baxter, Nancy N.;Warren, Joan L.;Doria-Rose, V. Paul
通讯作者: Doria-Rose, V. Paul
DOI: 10.1056/nejmoa1309086
发表时间: 2014-04-03
期刊: The New England journal of medicine
影响因子: --
作者:
Corley DA;Jensen CD;Marks AR;Zhao WK;Lee JK;Doubeni CA;Zauber AG;de Boer J;Fireman BH;Schottinger JE;Quinn VP;Ghai NR;Levin TR;Quesenberry CP
通讯作者: Quesenberry CP
DOI: 10.1002/cncr.28156
发表时间: 2013-08-01
期刊: CANCER
影响因子: 6.2
作者:
Cavanagh, Mary F.;Lane, Dorothy S.;Anderson, Joseph C.
通讯作者: Anderson, Joseph C.